1 0 7 1 IL-9 is a pleiotropic cytokine with high expression in the lungs of asthmatic patients 1,2 . Blocking antibodies to IL-9 are now in clinical trials as potential therapies for atopic disease 3 . In mouse models, specific overexpression of IL-9 in lungs induces an asthma-like phenotype [4] [5] [6] and blockage of IL-9 signaling results in less airway inflammation 7, 8 . In lung physiology, IL-9 has been proposed to induce mucous production, goblet cell hyperplasia and other features of airway remodeling 9,10 , functions also attributed to and IL-5 via the regulation of eosinophils 12 . IL-9 is also involved in protective immunity to helminth infections, as indicated by enhanced kinetics of worm expulsion in IL-9 transgenic mice 13,14 and susceptibility to helminth infection upon IL-9 depletion 15 .
IL-9 is a pleiotropic cytokine with high expression in the lungs of asthmatic patients 1, 2 . Blocking antibodies to IL-9 are now in clinical trials as potential therapies for atopic disease 3 . In mouse models, specific overexpression of IL-9 in lungs induces an asthma-like phenotype [4] [5] [6] and blockage of IL-9 signaling results in less airway inflammation 7, 8 . In lung physiology, IL-9 has been proposed to induce mucous production, goblet cell hyperplasia and other features of airway remodeling 9, 10 , functions also attributed to IL-13 (ref. 11 ) and IL-5 via the regulation of eosinophils 12 . IL-9 is also involved in protective immunity to helminth infections, as indicated by enhanced kinetics of worm expulsion in IL-9 transgenic mice 13, 14 and susceptibility to helminth infection upon IL-9 depletion 15 .
T cells are the main cellular source of IL-9 in the context of airway inflammation [16] [17] [18] . Activated CD4 + type 2 helper T cells (T H 2 cells) have been thought to comprise the majority of IL-9-producing cells. However, substantial IL-9 production is induced in CD4 + T cells differentiating in vitro in the presence of IL-4 and transforming growth factor-β but not with IL-4 alone 19 . Thus, IL-9 is not a T H 2 cytokine. In addition to T cells, eosinophils and mast cells also produce .
New cellular sources for the secretion of T H 2-type cytokines have been identified. These cell types are very similar to lymphoid tissue-inducer cells (LTi cells), do not express known lineage markers, respond to both IL-25 and IL-33 and have a protective role during helminth infections [23] [24] [25] [26] [27] [28] [29] . Such lineage-negative (Lin -) cells have some LTi-like properties, such as expressing IL-7 receptor, but do not express the coreceptor CD4 and the transcription factor RORγt and have a cytokine expression profile different from that of LTi cells. Therefore, they have been called natural helper cells (NHCs) 28 , nuocytes 27 , innate helper type 2 (Ih2) cells 29 or multipotent progenitors (MPPs) 26 .
Nuocytes and MPPs reside in mesenteric lymph nodes and spleen, NHCs are found in the fat-associated lymphoid tissue and Ih2 cells are dispersed throughout the body, with most Ih2 cells recovered from the liver. These subsets of newly identified Lin -cells, or innate lymphoid cells type 2 (ILC2s) 30 , are characterized by abundant secretion of the T H 2 cytokines IL-5, IL-6 and IL-13 after induction with IL-25 or IL-33, which suggests that they are involved in airway inflammation.
Here we show the induction of IL-9-producing ILCs identified by an IL-9-specific reporter in a model of papain-induced airway inflammation. ILCs were the main source of IL-9, and IL-9 production was transient and dependent on IL-2 from adaptive immune cells. Although IL-9 expression waned quickly, ILCs continued to produce IL-13 and IL-5. IL-9 facilitated production of IL-5 and IL-13 in ILCs, whereas neutralization of IL-9 resulted in lower expression of IL-5 and IL-13 after papain challenge. Our findings indicate a previously unrecognized mechanism for the induction of IL-9 in ILCs and the potential involvement of IL-9 in allergic lung diseases via promoting the production of IL-5 and IL-13 in ILCs.
RESULTS

IL-9 fate-reporter mice
Despite the demonstration that a subset of in vitro-generated CD4 + T cells can secrete IL-9 (ref. 19) , the cell types that produce this cytokine in vivo under physiological conditions have not been identified. This is partially because of the technical difficulties associated with ex vivo intracellular staining for IL-9. We generated IL-9 fatereporter mice with transgenic expression of a bacterial artificial chromosome (BAC) that express Cre recombinase under the control of the endogenous IL-9 locus (IL9 Cre mice; Supplementary Fig. 1 ).
To visualize Cre activity, we bred the IL9 Cre mice with reporter 1 0 7 2 VOLUME 12 NUMBER 11 NOVEMBER 2011 nature immunology A r t i c l e s mice expressing enhanced yellow fluorescent protein (eYFP) under the control of the endogenous Rosa 26 promoter (R26R eYFP ). In IL9 Cre R26R eYFP mice, the fluorescent reporter permanently labels cells that had expressed Il9 regardless of the present production status of this cytokine. By analysis of tissues from nonimmune IL9 Cre R26R eYFP reporter mice, we found no eYFP + cells in the hematopoietic compartment of peripheral lymph nodes, mesenteric lymph nodes, spleen, lung, liver, skin or lamina propria of small or large intestine (Supplementary Fig. 2) .
In vitro stimulation of flow cytometry-purified naive CD4 + T cells with transforming growth factor-β and IL-4 generated a population of the T H 9 subset of helper T cells that were detectable by intracellular staining for IL-9 and by eYFP expression (Supplementary Fig. 3a) . In agreement with published reports 31 , IL-9 expression in T cell cultures was transient. No eYFP induction occurred under conditions for the induction of T H 1, T H 2 or inducible regulatory T cells, although a proportion of eYFP-producing cells was induced under conditions for the induction of IL-17-producing helper T cells (T H 17 cells; Supplementary Fig. 3b ). However, only ~10% of the cells detected by intracellular cytokine staining had turned on the eYFP gene, which suggested incomplete reporting of IL-9-expressing cells. Our data showed that induction of transcripts encoding Cre from the BAC construct was considerably lower than the induction of endogenous IL-9 transcripts. This may have added to the observed under-reporting of the BAC transgene in this reporter line (Supplementary Fig. 3c ). Despite this limitation, IL9 Cre R26R eYFP mice are a useful tool for detecting IL-9 production in vivo.
IL-9 is expressed during papain-induced airway inflammation
Because IL-9 expression has been linked to lung inflammation, we studied the IL-9 expression pattern in IL9 Cre R26R eYFP mice in a setting of airway inflammation. Papain, a protease with adjuvant activity that leads to asthma-like responses 32 , induces a strong T H 2 phenotype after subcutaneous injection 33 and has been used to induce experimental airway inflammation 34, 35 . Intranasal challenge of IL9 Cre R26R eYFP reporter mice with papain induced robust T H 2-type lung inflammation, as monitored by cell influx in the lungs (Fig. 1a) and cytokine production in the airways (Fig. 1b) . Notably, papain-induced airway inflammation also led to IL-9 expression in the lung (Fig. 1b) , and analysis of reporter mice showed that most if not all eYFP expression was in non-T cells (Fig. 1c) . We further phenotyped these eYFP + cells and found that they were not related to any defined hematopoietic lineage (Fig. 1d) . We recovered no eYFP + Lin -cells from the lungs of mice challenged with PBS as control (Fig. 1e) .
To address whether the eYFP + cells that accumulated in papaininduced inflammation phenotypically resembled natural helper cells, Ih2 cells, nuocytes or MPPs [26] [27] [28] [29] , we further characterized their surface expression profile. Although eYFP + Lin -cells did not resemble any of the reported cell types, they shared the expression of Thy-1.2 and CD45, and most also expressed the IL-33 receptor (IL-33R), whereas expression of the differentiation marker Sca-1, major histocompatibility complex class II and the cytokine receptor CD25 had a more heterogeneous distribution (Fig. 1f ) . We did not detect substantial expression of IL-7R or the cell surface marker c-Kit (CD117) in eYFP + cells directly after papain challenge (data not shown). Thus, we found that ILCs were the main source of IL-9 in this model of lung inflammation.
Transient IL-9 but sustained production of IL-5 and IL-13 in ILCs We next examined the cytokine expression profile of eYFP + ILCs by intracellular cytokine staining 24 h after the final papain challenge. After a short 2.5-hour pulse with phorbol-12-13-dibutyrate (PdBU) and ionomycin, all eYFP + ILCs expressed IL-13 and the majority expressed IL-5, but only a minority produced IL-4 (Fig. 2a) . However, we found no IL-9 expression in these cells by intracellular cytokine staining (Fig. 2a) . IL-9 expression in CD4 + T cells in vitro suggested short-lived IL-9 production. To investigate whether IL-9 expression in 
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ILCs is similarly curtailed in papain-mediated airway inflammation, we did kinetic analysis of cytokine secretion after papain rechallenge in wild-type C57BL/6 (B6) mice. The frequency of IL-9 + ILCs recovered from the lungs of wild-type mice after papain challenge changed rapidly over time, with peak expression 6-12 h after challenge, and a rapid decrease by 24 h (Fig. 2b,c) . Analysis of IL-9 protein expression at 6, 12 or 24 h after papain challenge supported the assumption of transient IL-9 expression, with peak protein expression observed after 12 h (Fig. 2d) . ILCs isolated from reporter mice showed eYFP expression localized together with intracellular IL-9 at 12 h after papain rechallenge ( Supplementary Fig. 4 ). Thus, ILCs induced during papain-mediated lung inflammation rapidly lost expression of IL-9 protein in favor of expression of IL-5 and IL-13.
IL-9 expression in ILCs is induced by IL-2
To test the ability of ILCs to upregulate IL-9 expression after stimulation with Toll-like receptor (TLR) ligands, we cultured immunomagnetically selected ILCs (defined by the depletion of cells expressing the lineage markers TCRβ, TCRγδ, CD11c, CD11b, Gr-1, CD19, DX5, NK1.1 and Ter119) and Lin + cells isolated from papain-challenged wild-type mice ( Supplementary Fig. 5a ) in the presence of PdBU and iononomycin or TLR ligands. None of the TLR ligands tested induced IL-9 production in ILCs or in Lin + cells, whereas overnight stimulation with PdBU and ionomycin (rather than a 2.5-hour stimulation) induced IL-9 protein expression in ILCs (Supplementary Fig. 5b ). This suggested that IL-9 can be induced or reinduced in ILCs after extended stimulation or in response to secondary factors induced after stimulation with PdBU and ionomycin.
IL-25, IL-33, thymic stromal lymphopoietin (TSLP) or a combination of these cytokines did not induce substantial IL-9 production in ILCs isolated from papain-challenged mice (Supplementary Fig. 5c ).
However, culturing ILCs in the presence of IL-2 led to IL-9 protein expression similar to that observed after stimulation with PdBU and ionomycin (Fig. 3a) . CD25, the high-affinity chain of the IL-2 receptor, is expressed on a proportion of eYFP + ILCs, and ILCs produced IL-9 in response to IL-2 stimulation . To test whether CD25 expression can be used to identify ILCs poised for expression of IL-9 in wild-type B6 mice, we sorted CD25 + and CD25 -ILCs and tested their IL-2-induced IL-9 protein production compared with that of total CD4 + T cells from papain-challenged mice (Fig. 3b) . IL-2-mediated IL-9 production was present mainly in CD25 + ILCs (Fig. 3b) , which further emphasized an important role for IL-2 signaling in ILC production of IL-9. We detected no IL-9 production in CD4 + T cells. IL-9 expression in eYFP + ILCs isolated from IL9 Cre R26R eYFP reporter mice likewise depended on IL-2 (Fig. 3c) . Through analysis of cytokine mRNA expression, we compared lung-infiltrating unstimulated total CD4 + T cells (set as reference standard) with CD25 + or CD25 -ILCs from wild-type mice or eYFP + ILCs and found substantially greater expression of T H 2-type cytokines, such as IL-5, IL-6 and IL-13, in CD25 + ILCs and especially in eYFP + ILCs from the IL-9 reporter mice (Fig. 3d) , which emphasized their activated state. Expression of IL-9 was higher in CD25 + ILCs than in total CD4 + T cells or CD25 -ILCs. IL-9 mRNA was even more abundant in eYFP + ILCs from reporter mice, which supported A r t i c l e s the idea that eYFP specifically reports IL-9 expression. These data indicate that IL-9 production depends on the availability of IL-2.
IL-33 induces IL-9-competent ILCs but IL-25 does not
Although neither IL-25 nor IL-33 induced IL-9 production in ILCs, we did not test the ability of these cytokines to induce recruitment of ILCs and the potential for subsequent IL-9 induction after exposure to IL-2. To test whether IL-25-and IL-33-induced ILCs could produce IL-9 after IL-2 stimulation, we treated wild-type mice intranasally with IL-25 or IL-33. Intranasal challenge with IL-33 was much more potent than IL-25 treatment was in inducing the accumulation of ILCs in the lung (Fig. 4a,b) . Although IL-25 challenge led to the induction or recruitment of ILCs producing IL-13 (Fig. 4a,c) , production of this cytokine was again greater after IL-33 application. Whereas we detected no IL-9 + cells by intracellular cytokine staining, IL-33 induced abundant ILCs prone to IL-9 production after IL-2 stimulation (Fig. 4d) . IL-33-primed ILCs also expressed more IL-5 and IL-13 than did IL-25-primed ILCs (Fig. 4d) . IL-33 also more potently induced eYFP + ILCs after intranasal administration (Fig. 4e) , and these ILCs expressed IL-13 and had surface markers similar to those of the eYFP + ILCs generated during papain-induced lung inflammation (Supplementary Fig. 6 ). To compare IL-33-and papain-induced ILCs with other ILC2 types, we investigated the induction of eYFP expression in NHCs in the fat-associated lymphoid tissue or Ih2 cells in the liver or in nuocytes in the mesenteric lymph nodes after intraperitoneal injection of IL-25 and IL-33. Administration of IL-33, but not IL-25, induced a small percentage of eYFP + nuocytes, whereas we detected few eYFP + NHCs or Ih2 cells (Supplementary Fig. 7) . Thus, IL-33 mainly induces ILCs able to produce IL-9.
IL-9 expression requires IL-2 from adaptive immune cells
ILCs are present in mice deficient in recombination-activating gene 1 (Rag1 −/− mice), which lack T and B cells, but not in mice lacking the common γ-chain (IL2rg −/− mice) [27] [28] [29] . To investigate whether the population of IL-9-expressing cells is independent of expression of the RAG recombinase but dependent on signaling via the common γ-chain, we analyzed IL-9 expression in the lungs of papain-challenged wild-type, Rag1 −/− and Rag2 −/− IL2rg −/− mice. IL-9 production was much lower in the lungs of Rag1 −/− mice than in those of wild-type mice and was absent in Rag2 −/− IL2rg −/− mice (Fig. 5a) . IL-5 and IL-13 protein expression was also lower in Rag1 −/− mice than in wild-type mice in agreement with published reports that IL-13-expressing cells in the mesenteric lymph nodes are not maintained during helminth infection in Rag1 −/− mice 27 . However, isolation of ILCs from the lungs of papain-challenged wild-type, Rag1 −/− and Rag2 −/− IL2rg −/− mice, followed by overnight stimulation with IL-2, led to similar IL-9 protein expression in ILCs of wild-type and Rag1 −/− (Fig. 5b) . In contrast, ILCs isolated from Rag2 −/− IL2rg −/− mice did not produce IL-9 afterIL-2 stimulation (Fig. 5b) .
These results suggest that IL-9 production in ILCs after papain challenge in vivo depends on the presence of adaptive immune cells.
To address whether IL-2 is important for IL-9 expression after papain challenge in vivo, we treated wild-type mice with neutralizing antibodies to IL-2 at 30 min before the final papain challenge. IL-2 neutralization led to significantly lower IL-9 expression in papain-treated mice but not in mice treated with isotype-matched control antibody (Fig. 5c) . Other T H 2 cytokines, such as IL-4, IL-5, IL-6 and IL-13, were not affected by IL-2 neutralization, at least at the early time point of 18 h.
To further investigate whether the low expression of IL-9 protein in Rag1 −/− mice was caused by a lack of IL-2, we treated papain-challenged Rag1 −/− mice intranasally with IL-2 or PBS at 3 h after the final papain rechallenge. Treatment with IL-2 restored IL-9 expression in Rag1 −/− mice to wild-type expression, but treatment with PBS did not (Fig. 5d ) . Intranasal application of IL-2 alone, without papain challenge, did not lead to IL-9 production (Fig. 5d ) . Total ILC numbers in Rag1 −/− mice were only slightly, but not significantly, lower than in wild-type mice, and IL-2 application did not lead to more ILCs (Fig. 5e) . These results suggest that IL-9 protein production by ILCs depends critically on the provision of IL-2 by adaptive immune cells.
ILCs are the main source of IL-9 in papain-induced inflammation To investigate whether ILCs are the critical producers of IL-9 during papain-induced lung inflammation, we did intracellular cytokine staining for IL-9 and IL-13 in ILCs and CD4 + T cells. Most intracellular IL-9 was expressed in ILCs, although we detected a minor contribution from CD4 + T cells (Fig. 6a,b) . Although we recovered similar numbers of ILCs and CD4 + T cells from the lungs of papainchallenged mice (Fig. 6c) , expression of IL-9 and IL-13 stemmed almost exclusively from ILCs (Fig. 6d) .
To further explore the relative contribution of ILCs or CD4 + T cells to IL-9 production in papain-challenged mice, we adoptively transferred either ILCs or CD4 + T cells sorted from the lungs of papain-challenged wild-type mice intratracheally into Rag2 −/− IL2rg −/− hosts. In this setting, only transferred cells can respond to IL-2 and produce IL-9. Transfer was followed by challenge with papain and IL-2. We detected very little IL-9, IL-5 and IL-13 after transfer of CD4 + T cells, but transfer of ILCs led to much higher expression of IL-9, IL-5 and IL-13 (Fig. 6e,f) . In contrast, sensitization and challenge of IL9 Cre R26R eYFP mice with ovalbumin, a model in which T cells are reported to be the main producers of IL-9 (refs. [16] [17] [18] , led to eYFP expression largely restricted to CD4 + T cells rather than ILCs (Supplementary Fig. 8) . Thus, ILCs and not CD4 + T cells are the major producers of IL-9, IL-5 and IL-13 in this model.
IL-9 alters the cytokine expression and phenotype of ILCs
To investigate the potential physiological consequences of IL-9 expression during papain-induced airway inflammation, we treated wild-type mice with neutralizing antibody to IL-9 at 30 min before the final papain challenge. The number and composition of cells infiltrating the lungs and airways of papain-challenged mice was unchanged after IL-9 neutralization at this stage (data not shown) and the total number of ILCs did not change significantly (Fig. 7a,b) . However, we observed a considerable phenotypic change in the ILC population 3 d after papain challenge and IL-9 neutralization. Whereas ILCs from papain-challenged mice treated with isotype-matched control antibodies had high expression of CD25 and Sca-1, ILCs from IL-9 neutralized mice had substantially fewer CD25 + Sca-1 + cells (Fig. 7a,c) . The IL-9 receptor (IL-9R) is expressed on Ih2 cells 29 . To address whether ILCs recovered from the lung of papain-challenged mice expressed IL-9R, we sorted CD25 + ILCs and compared their IL-9R expression with that of B cells, which express IL-9R, and naive T cells, which do not express the receptor. CD25 + ILCs had IL-9R expression similar to that of B cells (Fig. 7d) , which indicated that IL-9 could directly affect ILCs. To investigate whether exposure to IL-9 changes the cytokine profile of ILCs, we cultured sorted CD25 + ILCs with or without IL-9. Addition of IL-9 resulted in much more production of IL-5, IL-6 and IL-13 by ILCs (Fig. 7e) , which suggested that IL-9 could provide an additional activation signal important for cytokine expression. To address whether IL-9 has a similar effect on the expression of IL-5 and IL-13 in vivo, we analyzed the lung homogenates and bronchoalveolar lavage fluid of papain-challenged mice treated with neutralizing IL-9-specific antibody or isotype-matched control antibody 3 d after challenge and neutralization of IL-9. In mice in which IL-9 was neutralized, IL-5 and IL-13 expression was less than half of that A r t i c l e s in mice treated with isotype-matched control antibody (Fig. 7f) , which indicated that IL-9 has an additive effect on the expression of IL-5 and IL-13 in vivo. Thus, IL-9 seems to have a feedback effect on ILCs, leading to upregulation of IL-5 and IL-13.
DISCUSSION
Several studies have linked IL-9 to lung inflammation, although the cell type responsible has not been identified owing to technical difficulties of intracellular staining for IL-9. To address the cellular source of IL-9 production in vivo, we generated an IL-9 fate-reporter strain. Initial in vitro tests on T cell differentiation established faithful reporter induction under T H 9 conditions. Even under T H 9 conditions, only ~10% of the IL-9 producers were marked by eYFP, which suggested incomplete reporter activity. There are several potential reasons for this limitation. First, the in vitro conditions for T H 9 induction could have been inefficient, as in the IL-17 Cre fate reporter 36 , which effectively induces eYPF in T H 17 cells generated in vivo but marks only ~30% of T H 17 cells generated in vitro. Second, the incomplete reporting could have been due to the BAC transgenic construct itself. The sequence containing internal ribosomal entry site and encoding the fluorescent protein Cherry in the construct was disabled owing to a premature translational start site in the IRES sequence, which possibly diminished translation from the ATG in the sequence encoding Cherry. The presence of a dysfunctional DNA sequence in the construct could interfere with reporter induction. Comparative analysis of transcripts for Cre versus endogenous IL-9 transcripts showed substantially less Cre induction, indicative of transcriptional dysregulation of the BAC transgene. However, we did not observe aberrant eYFP expression in a wide range of cell types, so despite the possibility that not all IL-9-producing cells were labeled by eYFP, we were able to identify a proportion of such cells with this reporter.
Four types of ILCs with similar surface markers and large amounts of the T H 2 cytokines IL-5 and IL-13 have been described [26] [27] [28] [29] . The eYFP + ILCs identified in our reporter system shared expression of the Thy-1.2 surface marker with nuocytes, NHCs, MPPs and Ih2 cells and shared expression of IL-33R and Sca-1 with nuocytes, NHCs and MPPs. Like nuocytes, they expressed major histocompatibility complex class II, and they shared CD25 expression with NHCs. Most eYFP + ILCs produced IL-5 and IL-13 but not IL-4 after restimulation. Although eYFP + ILCs showed alterations in surface marker expression compared with that of previously identified ILC types, we cannot exclude the possibility that the cells we identified are identical or similar to NHCs, MPPs or nuocytes. We instead propose that changes in surface marker expression reflect activation status and probably tissue distribution.
In contrast to the reported induction of the ILC cytokines IL-5, IL-6 and IL-13 by IL-25 or IL-33, IL-9 was not directly induced by the last two cytokines, but instead depended on IL-2. However, priming with IL-33 either recruited or induced the ILC population for IL-2-triggered IL-9 production, but priming with IL-25 did not. It has been reported that IL-9 induction in human T cells depends on IL-2 (refs. 37,38); however, we did not observe similar effects in sorted mouse T cells from papain-challenged mice. Because in most studies T cell purity has been assessed by CD2 staining and IL-9 has been measured by enzyme-linked immunosorbent assay, this did not exclude the possibility of ILC contamination. Although ILCs were present in papain-treated Rag1 −/− mice, IL-9 expression was considerably lower than that in papain-treated wild-type mice but was restored by application of IL-2. This suggests that cells absent from Rag1 −/− mice, such as T cells or natural killer T cells, could be the most important source of IL-2 to support IL-9 production by ILCs. IL-9 expression influenced the expression of other ILC cytokines because ILCs, like lh2 cells, have high expression of IL-9R transcripts 29 , and neutralization of IL-9 in the context of papain challenge led to considerable changes in surface phenotype in ILCs, with less CD25 and Sca-1. ILCs displaying CD25 had higher expression of IL-5, IL-6 and IL-13 than did CD25 -ILCs, which suggests that CD25 expression, as in T cells, could reflect activation. Sca-1 expression on hematopoietic stem cells is upregulated after inflammation 39 and higher Sca-1 expression on ILCs could likewise indicate inflammatory activation. Neutralization of IL-9 during papain-induced lung inflammation led to lower expression of IL-13 and IL-5 at 3 d after challenge. Because maintenance of IL-5 and IL-13 is linked to IL-9, and IL-9 induction requires IL-2, lack of IL-2 signaling might also affect the expression of IL-5 and IL-13. Although blockade of IL-2 led to downregulation of IL-9 early after papain challenge (18 h), there was no effect on IL-5 and IL-13 at this time point. The expression of IL-5 and IL-13 might be affected at later time points. Our data might explain the observation that although nuocytes are initially induced and accumulate in the mesenteric lymph nodes of Rag1 −/− mice infected by Nocardia brasiliensis , their numbers are not maintained without T cells 27 . In this study, nuocytes were defined by present reporting of IL-13 expression. We found lower IL-13 expression, but not fewer ILCs, in the lungs of papain-challenged Rag1 −/− mice. In contrast to a reporter of present cytokine production, the fate reporter allows detection of cells even after loss of cytokine expression. Thus, IL-2-mediated IL-9 expression might explain sustained IL-13 expression in nuocytes and in ILCs in general. Culture of NHCs with IL-2 alone or in combination with IL-33 promotes IL-13 expression 28 , which further indicates that IL-2 is the most probable connection to the adaptive immune system. Spontaneous IL-9-induced airway inflammation is observed in mice with transgenic IL-9 expression 6-8 but is ablated if such mice are backcrossed onto an IL-13-deficient background 6 . This indicates that IL-9 acts via expression of IL-13. Also, IL-13-producing ILCs cause lung pathology during influenza infection 40 ; however, the involvement of IL-9 was not investigated in that study.
IL-9 effects on intestinal mucosa have been reported to be IL-13 dependent 41 . Furthermore, blocking IL-5 in mice with transgenic IL-9 expression results in less eosinophil recruitment 8 , which suggests that IL-5 production in this spontaneous airway inflammation is also linked to IL-9. In agreement with those observations, our data showed upregulation of IL-13 and IL-5 in ILCs after IL-9 stimulation, which suggested that IL-9-mediated airway inflammation may be caused by enhanced expression of IL-13 and IL-5 in ILCs. It seems that IL-9 production must be curtailed and tightly regulated to prevent lung pathology. Thus, understanding the mechanism of transient IL-9 regulation might be essential for recognizing the pathological function of IL-9 during airway inflammation. Together our data suggest that ILCs are plastic and have a highly dynamic cytokine network.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
